Purpose: The series is designed to cover the logistics and the process of IND (and Exploratory IND) filing, the regulatory strategy required for IND approvals, and successful communications with the FDA. Attendees will learn tools and resources from experienced regulatory professionals that are necessary for filing IND submissions with the FDA.
Target Audience: Cancer center members and faculty researchers in the Molecular Imaging Program at Stanford.
Schedule: Seven Mondays excluding holidays starting January 10, 2011, 4:30-5:30 pm in the Clark Center Auditorium. February 14 and 28 sessions will be held at LKSC.